{"id":"https://openalex.org/W7225638375","doi":"https://doi.org/10.6084/m9.figshare.34954076","title":"Cost-effectiveness analysis of tarlatamab as second-line therapy for small-cell lung cancer after platinum-based chemotherapy","display_name":"Cost-effectiveness analysis of tarlatamab as second-line therapy for small-cell lung cancer after platinum-based chemotherapy","publication_year":2026,"publication_date":"2026-11-09","ids":{"openalex":"https://openalex.org/W7225638375","doi":"https://doi.org/10.6084/m9.figshare.34954076"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.34954076","doi":"https://doi.org/10.6084/m9.figshare.34954076","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34954076","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.34954076","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5138801696","display_name":"Zhengxiong Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhengxiong Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161343949","display_name":"Jiaming Zhu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiaming Zhu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5143515987","display_name":"Kai Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kai Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tarlatamab","display_name":"tarlatamab","score":1.0},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.8410000205039978},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9670000076293945},{"id":"https://openalex.org/keywords/incremental-cost-effectiveness-ratio","display_name":"incremental cost-effectiveness ratio","score":0.8109999895095825},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9330000281333923},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.44699999690055847},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6880000233650208},{"id":"https://openalex.org/keywords/payer-perspective","display_name":"payer perspective","score":0.5249999761581421}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.838699996471405},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6923999786376953},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6578999757766724},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.640999972820282},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.5511999726295471},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5375999808311462},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46299999952316284},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.41359999775886536},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.39579999446868896},{"id":"https://openalex.org/C21200559","wikidata":"https://www.wikidata.org/wiki/Q7451068","display_name":"Sensitivity (control systems)","level":2,"score":0.36579999327659607},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.3463999927043915},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34299999475479126},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.3084999918937683},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.29159998893737793},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.2879999876022339},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.2727000117301941},{"id":"https://openalex.org/C49937458","wikidata":"https://www.wikidata.org/wiki/Q2599292","display_name":"Probabilistic logic","level":2,"score":0.26460000872612},{"id":"https://openalex.org/C184834754","wikidata":"https://www.wikidata.org/wiki/Q358564","display_name":"Cost\u2013utility analysis","level":3,"score":0.2515999972820282},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.25049999356269836}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.34954076","doi":"https://doi.org/10.6084/m9.figshare.34954076","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34954076","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.34954076.v1","doi":"https://doi.org/10.6084/m9.figshare.34954076.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34954076.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.34954076","doi":"https://doi.org/10.6084/m9.figshare.34954076","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.34954076","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155504587","https://openalex.org/W7155533194","https://openalex.org/W7161788543","https://openalex.org/W7111693956","https://openalex.org/W4413376027","https://openalex.org/W4410961676","https://openalex.org/W4411913398","https://openalex.org/W7162675253","https://openalex.org/W4411025712","https://openalex.org/W4408988802"],"abstract_inverted_index":{"The":[0,121],"DeLLphi\u2011304":[1,72],"trial":[2],"demonstrated":[3],"that":[4,144],"tarlatamab":[5,32,104,130,145,166,196],"provides":[6],"superior":[7],"efficacy":[8,67],"compared":[9],"with":[10,14,102,107],"chemotherapy":[11,184],"in":[12],"patients":[13],"relapsed":[15],"small-cell":[16],"lung":[17],"cancer":[18],"(SCLC)":[19],"after":[20,182],"first\u2011line":[21],"platinum\u2011based":[22,183],"chemotherapy.":[23],"Our":[24],"study":[25],"aimed":[26],"to":[27,52,126,167,173,197],"evaluate":[28],"the":[29,40,61,71,80,115,127,132,150],"cost\u2011effectiveness":[30,63],"of":[31,110,119,129,134,153,158],"as":[33,176],"a":[34,47,141,177],"second\u2011line":[35,178],"treatment":[36,179],"for":[37,82,165,180,195],"SCLC":[38,181],"from":[39,70,79],"US":[41],"healthcare":[42],"payer":[43],"perspective.":[44],"We":[45],"developed":[46],"three-state":[48],"partitioned":[49],"survival":[50],"model":[51,97,122],"estimate":[53],"costs,":[54],"life\u2011years":[55,58],"(LYs),":[56],"quality\u2011adjusted":[57],"(QALYs),":[59],"and":[60,75,88,93,99,131],"incremental":[62],"ratio":[64],"(ICER).":[65],"Clinical":[66],"was":[68,105,123],"obtained":[69],"trial.":[73],"Costs":[74],"utilities":[76],"were":[77],"derived":[78],"Centers":[81],"Medicare":[83],"&":[84],"Medicaid":[85],"Services":[86],"data":[87],"published":[89],"literature.":[90],"Sensitivity,":[91],"scenario,":[92],"subgroup":[94],"analyses":[95],"assessed":[96],"uncertainty":[98],"heterogeneity.":[100],"Compared":[101],"chemotherapy,":[103],"associated":[106],"an":[108],"ICER":[109],"$1,145,233.86/QALY,":[111],"which":[112],"substantially":[113],"exceeded":[114],"willingness\u2011to\u2011pay":[116],"(WTP)":[117],"threshold":[118,152],"$150,000/QALY.":[120,154],"most":[124],"sensitive":[125],"cost":[128],"utility":[133],"progression-free":[135],"survival.":[136],"Probabilistic":[137],"sensitivity":[138],"analysis":[139],"indicated":[140],"0%":[142],"probability":[143],"would":[146,162],"be":[147,163,174,193],"cost-effective":[148],"at":[149,185],"WTP":[151],"A":[155],"price":[156,190],"reduction":[157],"more":[159],"than":[160],"82.34%":[161],"required":[164],"achieve":[168],"cost\u2011effectiveness.":[169],"Tarlatamab":[170],"is":[171],"unlikely":[172],"cost\u2011effective":[175],"its":[186],"current":[187],"price.":[188],"Substantial":[189],"reductions":[191],"may":[192],"necessary":[194],"become":[198],"cost-effective.":[199]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-10T00:00:00"}